{"created":"2021-03-01T06:29:34.847426+00:00","id":24237,"links":{},"metadata":{"_buckets":{"deposit":"c5cbc226-0f31-4e24-bdd0-3e9189b90e1f"},"_deposit":{"id":"24237","owners":[],"pid":{"revision_id":0,"type":"depid","value":"24237"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00024237","sets":["453:456","471:537:538:1236"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Platelet Transfusion in Hematologic Disorders (Indications and Problems in Tranfusion of Blood Components as of 1986)"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1987-03","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"180","bibliographicPageStart":"173","bibliographicVolumeNumber":"101","bibliographic_titles":[{"bibliographic_title":"新潟医学会雑誌"},{"bibliographic_title":"新潟医学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thrombocytopenic purpura (ITP), and platelet dysfunction gained from our clinical experiences. During intensive chemotherapy to patients with leukemia, prophylactic and/or therapeutic platelet transfusions were administered when their platelet counts were less than 20,000/ul. When disseminated intravascular coagulation (DIC) complication occured, we kept their platelet levels at more than 50,000/ul by heparin and platelet concentrates (PC). We also gave 2 or 3 times more PC than usual when infection or fever was noticed. In patients with aplastic anemia, if their platelet count was above 5,000/ul and general condition was steady they did not hemorrhage. Therefore, we ordered PC tranfusions when their platelet level was less than 5,000/ul and administered threefold PC to patients with infection or high fever. Platelet transfusion was mandatory when hemorrhaging because patient’s condition could deteriorate rapidly. Although we did not usually transfuse PC to ITP patients, we gave PC, corticosteroids and high doses of immunoglobulins to special cases showing life. threatening organ bleeding, with remarkable effects. In cases of plalelet dysfunction, PC indications were almost the same as in thrombocytopenic states described of leukemia. In a girl with hereditary thromboasthenia, who experienced massive hematemesis or melena occasionally, local treatments were important to stop bleeding as well as PC transfusion.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"145028","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Nagayama, Reizo"}]},{"nameIdentifiers":[{"nameIdentifier":"145029","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Sato, Ken"}]},{"nameIdentifiers":[{"nameIdentifier":"145030","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Shibata, Akira"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟医学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"長山, 礼三"}],"nameIdentifiers":[{"nameIdentifier":"145025","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"佐藤, 健"}],"nameIdentifiers":[{"nameIdentifier":"145026","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"柴田, 昭"}],"nameIdentifiers":[{"nameIdentifier":"145027","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-19"}],"displaytype":"detail","filename":"101(3)_173-180.pdf","filesize":[{"value":"468.5 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"101(3)_173-180.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/24237/files/101(3)_173-180.pdf"},"version_id":"bc682fe1-d878-4426-8c26-9cd8829cf330"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"platelet transfusion","subitem_subject_scheme":"Other"},{"subitem_subject":"leukemia","subitem_subject_scheme":"Other"},{"subitem_subject":"aplastic anemia","subitem_subject_scheme":"Other"},{"subitem_subject":"ITP","subitem_subject_scheme":"Other"},{"subitem_subject":"platelet dysfunction","subitem_subject_scheme":"Other"},{"subitem_subject":"血小板輸血","subitem_subject_scheme":"Other"},{"subitem_subject":"白血病","subitem_subject_scheme":"Other"},{"subitem_subject":"再生不良性貧血","subitem_subject_scheme":"Other"},{"subitem_subject":"特発性血小板減少性紫斑病","subitem_subject_scheme":"Other"},{"subitem_subject":"血小板機能異常","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"5) 血液疾患における血小板輸血(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"5) 血液疾患における血小板輸血(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)"},{"subitem_title":"5) 血液疾患における血小板輸血(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1236"],"pubdate":{"attribute_name":"公開日","attribute_value":"2016-01-07"},"publish_date":"2016-01-07","publish_status":"0","recid":"24237","relation_version_is_last":true,"title":["5) 血液疾患における血小板輸血(シンポジウム 血液製剤の輸血適応と問題点, 1986年, 第420回新潟医学会例会)"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:54:21.089463+00:00"}